- Home
- KLXE vs PPCB Comparison
KLXE vs PPCB Comparison
Compare KLXE & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLXE
- PPCB
- Stock Information
- Founded
- KLXE 2018
- PPCB 2007
- Country
- KLXE United States
- PPCB Australia
- Employees
- KLXE N/A
- PPCB N/A
- Industry
- KLXE Oilfield Services/Equipment
- PPCB
- Sector
- KLXE Energy
- PPCB
- Exchange
- KLXE Nasdaq
- PPCB Nasdaq
- Market Cap
- KLXE 35.8M
- PPCB 39.1M
- IPO Year
- KLXE N/A
- PPCB N/A
- Fundamental
- Price
- KLXE $1.81
- PPCB $2.18
- Analyst Decision
- KLXE
- PPCB
- Analyst Count
- KLXE 0
- PPCB 0
- Target Price
- KLXE N/A
- PPCB N/A
- AVG Volume (30 Days)
- KLXE 86.8K
- PPCB 1.9M
- Earning Date
- KLXE 10-30-2025
- PPCB 09-30-2025
- Dividend Yield
- KLXE N/A
- PPCB N/A
- EPS Growth
- KLXE N/A
- PPCB N/A
- EPS
- KLXE N/A
- PPCB N/A
- Revenue
- KLXE $667,400,000.00
- PPCB N/A
- Revenue This Year
- KLXE N/A
- PPCB N/A
- Revenue Next Year
- KLXE $3.97
- PPCB N/A
- P/E Ratio
- KLXE N/A
- PPCB N/A
- Revenue Growth
- KLXE N/A
- PPCB N/A
- 52 Week Low
- KLXE $1.46
- PPCB $0.00
- 52 Week High
- KLXE $7.40
- PPCB $145.46
- Technical
- Relative Strength Index (RSI)
- KLXE 47.79
- PPCB N/A
- Support Level
- KLXE $1.73
- PPCB N/A
- Resistance Level
- KLXE $1.94
- PPCB N/A
- Average True Range (ATR)
- KLXE 0.12
- PPCB 0.00
- MACD
- KLXE -0.01
- PPCB 0.00
- Stochastic Oscillator
- KLXE 23.40
- PPCB 0.00
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About PPCB Propanc Biopharma Inc.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.